TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: absolute change in BMI (kg/m²)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular pressure (IOP) measurement variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interoperator reproducibility of RT measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interdevice reproducibility of RT measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: supra-threshold auditory processing abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOFA score increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of UI (Urinary Incontinence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in PFM (Pelvic Floor Muscles) power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of hospital stay (LHS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: delayed drop of ≥1 point in ALSFRS‐R item score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delayed score transition from 4 or 3 at baseline to ≤2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delayed worsening of ALSAQ‐40 domain scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative complications (Comprehensive Complication Index, CCI®)
Endpoint domain: Adverse events/effects
Primary endpoint: Ease of use of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of expert feedback
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sagittal balance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronal balance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of intrathoracic pressure overshoot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elevation in airway peak pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: total number of suicide events
Endpoint domain: Mortality/survival
Primary endpoint: Primary outcome achievement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence from non-prescribed opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC A1 score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: narcotic pills used
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of residents achieving UPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance on PCAT components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DED symptoms by OSDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DED symptoms by BODI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite DED sign score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mVSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: vascularity subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: QoR-40 scores on POD1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total gaze time on the AOI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to fixate on the AOI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early crestal bone loss (MCBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fear responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intrusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ability to recognize anatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ability to identify pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depth perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinically serious hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Attitudes and intentions toward masking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: postoperative pain loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tonsillar fossa wound healing scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rate for subsequent donations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decisional Conflict Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decisional Regret Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MSSKQ Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with overall interest, ergonomics, realism, immersion and training efficiency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mediolateral amplitude (ML Amp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mediolateral root mean square
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total velocity for FSST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC-pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC physical functioning scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical component scores of HRQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perceived Self‐Efficacy scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Naloxone administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: treatment completion outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse events of interest
Endpoint domain: Adverse events/effects
Primary endpoint: self-report pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional limitation of the jaw
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: generalized pain sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work absorption
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Performance on Stroop test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: cf-PWV increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: thoracic aorta diameter increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: aortic stiffness increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mean change in mTSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mental health-related quality of life (HRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: knee-extension strength in the fractured leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma TG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LPL activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resting global CBF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Regional blood flow in the right hippocampus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Functional connectivity to the left superior parietal lobule
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of COVID-19 onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of implants requiring angled or straight abutments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Required angular correction to a screw-retained restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Preference for provider-delivered HIV testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of SacralStim system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of SacralStim system
Endpoint domain: Adverse events/effects
Primary endpoint: PC-AKI rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maternal knowledge regarding early parenting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: healthcare adherence
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Fagerström Nicotine Dependence Index (FTND) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: core depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: suicidality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Medial posterior tibial slope (MPTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral posterior tibial slope (LPTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior tibial slope (PTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life deterioration (≥ 5 points decrease from baseline in FACT-G)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: joint pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer blind spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: longer inspection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy for detecting gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: impact on patient safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from renal replacement therapy (RRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Major adverse renal and cardiovascular events (MARCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: new HIV diagnoses made per index participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Walking distance in ISWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: increase in flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average threshold (AT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foveal sensitivity (FS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postpartum diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: postpartum prediabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pain interference scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual efficacy of pirimiphos‐methyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of live birth
Endpoint domain: Mortality/survival
Primary endpoint: PTH concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Phosphate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CTX concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone health outcomes
Primary endpoint: Compliance with prescribed therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of Gram-positive anaerobic rods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction of Gram-negative aerobic rods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Diversity of detected species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically important GI bleedings in ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: SF-12 Mental Component Summary (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SF6D-R2 Utility index scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ASD symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of ASD classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative incidence of grade ? 2 late GI toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: cumulative incidence of grade ? 2 any late toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: 3-year pelvic relapse-free survival
Endpoint domain: Mortality/survival
Primary endpoint: upper chest mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower chest mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superficial trunk muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSQ total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: negative (clean) urine screens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of heavy alcohol use days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of marijuana use days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central cornea thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean deviation of the visual field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: median Wexner incontinence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linear increase in BSP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in alveolar process deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prenatal care attendance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum visit attendance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional scores of KSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wound surface area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Postpartum urinary retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Skin brightness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Erythema area improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Seborrheic dermatitis scales reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pruritus incidence reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: TEWL score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Return to normal glycemic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of Hs-CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: area under the ROC curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median duration of PFS
Endpoint domain: Mortality/survival
Primary endpoint: Clinically relevant bleeding events (BARC types 2, 3, or 5)
Endpoint domain: Adverse events/effects
Primary endpoint: 4-hour C-peptide AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial-remission response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical irritation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: corneometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Atazanavir concentration in hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TFLL (Tear Film Break-Up Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Frequency of artificial tears usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean BCVA gain from baseline to month 36
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSFT decrease from baseline to month 36
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diabetes burden of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: parental treatment satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Distance covered in the 6-min walk/run test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of fetal weight prediction model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total mean area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time to relevant wound area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-Hour urine levels of K+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-Hour urinary Na+/K+ levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Deaths associated with sepsis
Endpoint domain: Mortality/survival
Primary endpoint: Bond strength (BS) of RC filling material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median change of HII
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: engagement in EOLD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 30-year radiation-related absolute excess overall cardiovascular mortality
Endpoint domain: Mortality/survival
Primary endpoint: 30-year excess incidence of cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: patient-reported QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: waiting times for therapy administration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean HbA1c reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elastic Modulus of Lumbar Spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of C-reactive protein, procalcitonin, and serum protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean PBAC-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trajectory of congruence growth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total hospitalization costs
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Vaccine effectiveness (VE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes